I claim:
1. A method for inhibiting disorders characterized by elevated levels of basic fibroblast growth factor comprising administering to the individual having the disorder an effective amount of a curcuminoid to inhibit the basic fibroblast growth factor.
2. The method of claim I wherein the curcuminoid is administered topically.
3. The method of claim 1 wherein the disorder is bladdar or cervical cancer.
4. A method for inhibiting skin disorders selected from the group consisting of lymphangiogenesis, hemangioma of childhood, Sturge-Weber syndrome, verruca vulgaris, neurofibromatosis, tuberous sclerosis, pyogenic granulomas, recessive dystrophic epidermolysis bullosa, venous ulcers, acne, rosacea, eczema, molluscum contagious, seborrheic keratosis, and actinic keratosis comprising administering to the individual in need of treatment thereof an angiogenesis inhibitor in an amount effective to inhibit angiogenesis.
5. The method of claim 4 wherein the angiogenesis inhibitor is applied topically.
6. The method of claim 5 wherein the angiogenesis inhibitor is selected from the group consisting of collagenase inhibitors, endostatin, angiostatin, fumagillin derivatives like TNP-470, 2,5-diaryltetrahydrofurans, aminophenylphosphonic acid compounds, 3-substituted oxindole derivatives, thalidomides, penicillamine and IL12.
7. The method of claim 4 wherein the angiogenesis inhibitor is a curcuminoid.
8. The method of claim 7 wherein the angiogenesis inhibitor is curcumin.
9. The method of claim 7 wherein the angiogenesis inhibitor is demethoxycurcumin.
10. A method to treat a disorder selected from the group consisting of angiosarcoma, hemangioendothelioma, basal cell carcinoma, squamous cell carcinoma, malignant melanoma and Karposi’s sarcoma, and psoriasis, comprising administering to the individual in need of treatment an effective amount to inhibit angiogenesis of a curcuminoid.
11. The method of claim 10 wherein the angiogenesis inhibitor is curcumin.
12. The method of claim 10 wherein the angiogenesis inhibitor is demethoxycurcumin.
13. A pharmaceutical composition comprising a curcumin in combination with a pharmaceutically acceptable carrier for topical administration, wherein the curcumin is present in a dosage effective to treat a condition selected from the group consisting of lymphangiogenesis, hemangioma of childhood, Sturge-Weber syndrome, verruca vulgaris, neurofibromatosis, tuberous sclerosis, pyogenic granulomas, recessive dystrophic epidermolysis bullosa, venous ulcers, acne, rosacea, eczema, molluscum contagious, seborrheic keratosis, and actinic keratosis.
14. The composition of claim 13 wherein the carrier is an ointment or gel.
15. The composition of claim 14 as an ointment or hydrogel containing between one-half percent (0.5%) and five percent (5%) of the curcuminoid.
16. The composition of claim 13 wherein the carrier is a polymer formulation for implantation.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An incoming call display method applied to an electronic device configured to communicate with another electronic device via a network, the incoming call display method comprising:
displaying selectively a first display, a second display and a third display as a response display on a display module when receiving an incoming call from the other electronic device, the response display being configured to indicate how to respond to the incoming call, the first display being configured to indicate a response with video, the second display being configured to indicate a response by only voice, the third display being configured to indicate no response.
2. The incoming call display method of claim 1, further comprising:
displaying the response display at a position in a video display displayed on the display module when receiving the incoming call while viewing a program by use of the electronic device, the video display being configured to display the program.
3. An electronic device configured to communicate with another electronic device via a network, the electronic device comprising:
a display controller configured to display selectively a first display, a second display, and a third display as a response display on a display module when receiving an incoming call from the other electronic device, the response display being configured to indicate how to respond to the incoming call, the first display being configured to indicate a response with video, the second display being configured to indicate a response by only voice, the third display being configured to indicate no response.
4. The electronic device of claim 3, wherein
the display controller is configured to display the response display at a position in a video display displayed on the display module when receiving the incoming call while viewing a program by use of the electronic device, the video display being configured to display the program.
5. An incoming call display system comprising:
a first electronic device and a second electronic device configured to communicate with each other via a network, wherein
the first electronic device comprises a display controller configured to display selectively a first display, a second display and a third display as a response display on a display module when receiving an incoming call from the second electronic device, the response display being configured to indicate how to respond to the incoming call, the first display being configured to indicate a response with video, the second display being configured to indicate a response by only voice, the third display being configured to indicate no response.
6. The incoming call display system of claim 5, wherein
the display controller is configured to display the response display at a position in a video display displayed on the display module when receiving the incoming call while viewing a program by use of the first electronic device, the video display being configured to display the program.